Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,892 total articles

Melco Resorts Announces Unaudited First Quarter 2026 Earnings

Melco Resorts Announces Unaudited First Quarter 2026 Earnings

Melco Resorts & Entertainment Limited reported its unaudited Q1 2026 financial results, showing a notable 11% increase in total operating revenues to $1.37 billion, driven primarily by improved mass market operations. The company also recorded a 153% increase in net income attributable to shareholders, reaching $76.8 million ($0.20 per ADS). Adjust…

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Inspira Technologies has entered into a Joint Development Agreement with Qarakal Quantum to test and develop high-performance cryogenic interconnects using Inspira's 3D-printed electronics platform to address key scaling challenges in superconducting quantum computers. This collaboration will involve multi-phase engineering programs to evaluate tec…

Kaltura Announces "Connect on the Road 2026 – The Enterprise is Breaking the Fourth Wall" Conference: Join Experts from IBM, AWS, Morgan Stanley, Palo Alto Networks, MetLife, and more in Exploring the End of the Enterprise Monologue

Kaltura Announces "Connect on the Road 2026 – The Enterprise is Breaking the Fourth Wall" Conference: Join Experts from IBM, AWS, Morgan Stanley, Palo Alto Networks, MetLife, and more in Exploring the End of the Enterprise Monologue

Kaltura, a US-listed digital experience company, announced its annual 'Connect on the Road 2026' conference to be held in New York, San Francisco, and London. The event focuses on transforming enterprise digital interactions from monologues to AI-powered, hyper-personalized conversations using agentic avatars and rich media. The conference features…

Diginex Issues Corporate Update Highlighting Strategic AI Transformation, $1.5 Billion Resulticks Acquisition with Strong EBITDA Profile of US$46–50 Million, and Disciplined Funded Growth Strategy

Diginex Issues Corporate Update Highlighting Strategic AI Transformation, $1.5 Billion Resulticks Acquisition with Strong EBITDA Profile of US$46–50 Million, and Disciplined Funded Growth Strategy

Diginex Limited has announced a transformative corporate update including a proposed $1.5 billion all-share acquisition of Resulticks Global Companies. This acquisition will bolster Diginex’s platform by integrating ESG data with real-time customer engagement and AI-driven decisioning. Resulticks contributes approximately $150 million in annual rev…

Integer Holdings Corporation Reports First Quarter 2026 Results

Integer Holdings Corporation Reports First Quarter 2026 Results

Integer Holdings Corporation announced Q1 2026 results showing a slight sales increase but declines in adjusted operating income and net income compared to the previous year. The company updated its 2026 outlook reflecting headwinds related to new products and noted an ongoing strategic review to maximize shareholder value. Despite near-term challe…

Immutep Receives Nasdaq Notice of Bid Price Deficiency

Immutep Receives Nasdaq Notice of Bid Price Deficiency

Immutep Limited announced it has received a Nasdaq notice for not meeting the minimum $1.00 bid price requirement for its American Depositary Shares (ADS) over 30 consecutive business days. The company has 180 days to regain compliance, or risk delisting. The company continues to be listed on the Australian Securities Exchange (ASX) without impact.

Immutep Quarterly Activities Report Q3 FY26

Immutep Quarterly Activities Report Q3 FY26

Immutep Limited announced the discontinuation of its TACTI-004 Phase III trial evaluating eftilagimod alfa in first-line non-small cell lung cancer due to futility findings. The company is conducting a root cause analysis to understand the unexpected poor performance of the combination therapy and assessing implications for the broader eftilagimod …

Integer Announces Strategic Review to Maximize Stockholder Value

Integer Announces Strategic Review to Maximize Stockholder Value

Integer Holdings Corporation announced that its Board of Directors has launched a strategic review to evaluate a full range of opportunities, including a potential sale, merger, or strategic business combination, aiming to maximize value for shareholders. The Board remains confident in Integer's standalone strategy but is responding to strong inter…

ITW Reports First Quarter 2026 Results

ITW Reports First Quarter 2026 Results

Illinois Tool Works Inc. reported solid first quarter 2026 results with revenue of $4.02 billion representing a 5% increase. Operating margin improved to 25.4%, driving a 12% increase in GAAP EPS to $2.66. The company raised its full-year 2026 GAAP EPS guidance to a range of $11.10 to $11.50, indicating strong confidence in continued growth and mar…

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

ALX Oncology announced new data from its Phase 1b/2 trial of evorpacept combined with zanidatamab will be presented at the ESMO Breast Cancer 2026 Congress, highlighting biomarker analyses predictive of response in HER2-positive metastatic breast cancer. The company also plans to report Q1 2026 financial results and host a conference call with expe…

GPGI Announces Date of First Quarter 2026 Earnings Call

GPGI Announces Date of First Quarter 2026 Earnings Call

GPGI, Inc. announced that it will hold its first quarter 2026 earnings conference call on May 7, 2026, to discuss financial results for the period ending March 31, 2026. The call will include a Q&A session and a prior press release detailing earnings. GPGI is a diversified, multi-industry company operating under a permanent capital base with a focu…

Atlantic International’s Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands

Atlantic International’s Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands

Atlantic International Corp announced its subsidiary Circle8 Netherlands achieved a top-five ranking among Dutch workforce solutions firms and a 15.2% organic growth rate, generating $1.4 billion annual gross revenue. This growth supports Atlantic's ongoing expansion in IT and technology services across Europe, including AI, cybersecurity, and data…

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

Solid Biosciences Inc. announced its largest scientific presence at the 29th Annual Meeting of the American Society of Gene & Cell Therapy, with 5 oral presentations and 11 posters showcasing advancements in its gene therapy pipeline targeting neuromuscular and cardiac diseases. The presentations reflect progress in clinical development, delivery t…

Commerce Introduces New Product Innovations Across Storefronts, B2B, Payments and AI-Driven Commerce at Commerce Live 2026

Commerce Introduces New Product Innovations Across Storefronts, B2B, Payments and AI-Driven Commerce at Commerce Live 2026

Commerce (Nasdaq: CMRC) announced a broad range of product innovations at Commerce Live 2026 aimed at enhancing core platform capabilities, expanding storefront and B2B functionalities, elevating payment solutions, and introducing AI-driven agentic commerce features. The company highlighted improvements such as multi-language support, advanced prom…

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

OPKO Health’s subsidiary, BioReference Health LLC, announced the launch of BioReference Direct, a new digital platform allowing consumers to order high-quality laboratory tests online without needing an in-office visit. This platform includes tests for general wellness, men’s and women’s health, and an at-home self-collection STI test in collaborat…